drugset / Trial / NCT02756546
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis
RandomizedParallel-groupOpen-labelDiagnostic
Summary
This study aims to identify the expression signature of miR-181a, miR-196a and miR-21 in plasma of SLE patients and difference in their expression among groups with different systemic lupus erythematosis disease activity index (SLEDAI) scores.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-09
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cyclophosphamide | Other / unclassified | — | — |
| Comparator | Hydrocortisone | Other / unclassified | — | — |
| Comparator | Hydroxychloroquine | Small molecule | — | — |